Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Preliminary evaluation of variable compliance joystick for people with multiple sclerosis.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
The effect of exercise on depressive symptoms in adults with neurological disorders: A systematic review and meta-analysis.
Impaired health-related quality of life predicts progression of disability in multiple sclerosis.
Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI.
Simvastatin Treatment of Patients With Acute Optic Neuritis
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
Long-term benefits of induction therapy in NMO: a case report.
The role of invariant NKT cells in organ-specific autoimmunity.
In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.
Field potential recording from rat hippocampus provides a functional evaluation method for assessing demyelination and myelin repair.
On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis.
Safety and efficacy of natalizumab in children with multiple sclerosis.
Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.
Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model.
Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
383
384
385
386
387
388
389
390
391
…
next ›
last »